Literature DB >> 17229817

Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.

Queenie Lai Kwan Lam1, Cherry Kam Chun Lo, Bo-Jian Zheng, King-Hung Ko, Dennis G Osmond, Gillian E Wu, Robert Rottapel, Liwei Lu.   

Abstract

Previous studies on c-Abl-deficient mice have shown high post-natal mortality and lymphopenia. However, the mechanisms by which c-Abl may influence B lymphopoiesis remain obscure. In this study, we analyzed B cell sub-populations at various differentiation stages in the bone marrow (BM) of c-Abl-deficient mice. Phenotypic analyses revealed that c-Abl(-/-) pro-B cells were reduced to half of normal incidence and absolute number, while pre-B cells showed an even greater reduction. Both c-Abl(-/-) pro-B and pre-B cell populations showed considerably elevated apoptosis ex vivo and in short-term culture but their cell cycle progression was not impaired. In contrast, apoptosis of immature IgM(+)IgD(-) B lymphocytes remained at normal control levels. Inhibition of c-Abl activity by STI571 in normal BM cultures significantly increased apoptosis in B cell precursors while the survival of immature B cells was not affected. To determine whether c-Abl deficiency affects Ig heavy-chain rearrangement, we found that the frequency of V(D)J recombination was markedly reduced by 15-fold in c-Abl(-/-) pro-B cells compared with the control values. However, no perturbation in the levels of signal-end recombination intermediates was found. Taken together, we propose that c-Abl mediates a stage-specific anti-apoptotic response in precursor B cells and is required for efficient V(D)J recombination during B cell development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229817     DOI: 10.1093/intimm/dxl143

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation.

Authors:  Rachel A Liberatore; Stephen P Goff
Journal:  Int Immunol       Date:  2009-02-19       Impact factor: 4.823

2.  The effects of c-Abl mutation on developing B cell differentiation and survival.

Authors:  Hans Brightbill; Mark S Schlissel
Journal:  Int Immunol       Date:  2009-03-19       Impact factor: 4.823

3.  Effects of skeletal unloading on the bone marrow antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice.

Authors:  Trisha A Rettig; Nina C Nishiyama; Michael J Pecaut; Stephen K Chapes
Journal:  Life Sci Space Res (Amst)       Date:  2019-06-14

Review 4.  Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report.

Authors:  Tatiana V Beketova; Mikhail Y Volkov; Evgeniy A Naryshkin; Tatiana M Novoselova; Evgeniy L Nasonov
Journal:  Clin Rheumatol       Date:  2018-03-21       Impact factor: 2.980

Review 5.  Why does cytotoxic chemotherapy cure only some cancers?

Authors:  Philip Savage; Justin Stebbing; Mark Bower; Tim Crook
Journal:  Nat Clin Pract Oncol       Date:  2008-11-04

6.  T cell survival and function requires the c-Abl tyrosine kinase.

Authors:  Isabelle Silberman; Ronit Vogt Sionov; Valentina Zuckerman; Sue Haupt; Zehavit Goldberg; Andreas Strasser; Zami S Ben-Sasson; Michal Baniyash; Anthony J Koleske; Ygal Haupt
Journal:  Cell Cycle       Date:  2008-12-23       Impact factor: 4.534

7.  Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis.

Authors:  Masayuki Iyoda; Kelly L Hudkins; Shirly Becker-Herman; Tomasz A Wietecha; Miriam C Banas; Shunhua Guo; Almut Meyer-Bahlburg; Jolanta Kowalewska; Gang Liu; Steven F Ziegler; David J Rawlings; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 10.121

Review 8.  Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling.

Authors:  Marcus R Clark; Malay Mandal; Kyoko Ochiai; Harinder Singh
Journal:  Nat Rev Immunol       Date:  2013-12-31       Impact factor: 53.106

9.  Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.

Authors:  Elisabeth P Nacheva; Diana Brazma; Anna Virgili; Julie Howard-Reeves; Anastasios Chanalaris; Katya Gancheva; Margarita Apostolova; Mikel Valgañon; Helen Mazzullo; Colin Grace
Journal:  BMC Genomics       Date:  2010-01-18       Impact factor: 3.969

10.  Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency.

Authors:  Peter D Pioli; Timothy J Dahlem; Janis J Weis; John H Weis
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.